• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎克雷伯菌血流感染患者的临床特征和死亡风险因素。

Clinical features and risk factors for mortality in patients with Klebsiella pneumoniae bloodstream infections.

机构信息

Department of Critical Care Medicine, Taizhou Municipal Hospital, Taizhou, Zhejiang 318000, China.

Department of Critical Care Medicine, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, Zhejiang 318050, China.

出版信息

J Infect Dev Ctries. 2024 Jun 30;18(6):843-850. doi: 10.3855/jidc.18649.

DOI:10.3855/jidc.18649
PMID:38990987
Abstract

INTRODUCTION

Concern about Klebsiella pneumoniae (K. pneumoniae) bloodstream infections (KP-BSIs) is widespread because of their high incidence and lethality. The aim of this study was to investigate the clinical features of, and risk factors for mortality caused by KP-BSIs.

METHODOLOGY

This was a single-center retrospective observational study performed between 1 January 2019 and 31 December 2021, at a tertiary hospital. All patients with KP-BSIs were enrolled and their clinical data were retrieved from electronic medical records.

RESULTS

A total of 145 patients were included (121 in the survival group and 24 in the non-survival group). There was a higher proportion of lower respiratory tract infections in the non-survival group than in the survival group (33.3% vs. 12.4%) (p < 0.05). There was a higher proportion of multi drug resistant (MDR) strains of K. pneumoniae in the non-survival group than in the survival group (41.7% vs. 16.5%) (p < 0.05). Multivariate analysis revealed that sequential organ failure assessment (SOFA) score > 6.5 (OR, 13.71; 95% CI, 1.05-179.84), admission to the intensive care unit (ICU) (OR, 2.27; 95% CI, 0.26-19.61) and gastrointestinal bleeding (OR, 19.97; 95% CI, 1.11-361.02) were independent risk factors for death in patients with KP-BSIs.

CONCLUSIONS

Among all KP-BSIs, a high proportion of K. pneumoniae originated from lower respiratory tract infections, and a high proportion of K. pneumoniae were MDR; however, mortality was not influenced. SOFA score > 6.5, admission to the ICU, and gastrointestinal bleeding were independent risk factors for death in patients with KP-BSI.

摘要

简介

由于肺炎克雷伯菌(K. pneumoniae)血流感染(KP-BSIs)的高发病率和致死率,人们普遍对其表示担忧。本研究旨在调查 KP-BSIs 的临床特征和死亡相关的危险因素。

方法

这是一项单中心回顾性观察研究,于 2019 年 1 月 1 日至 2021 年 12 月 31 日在一家三级医院进行。所有患有 KP-BSIs 的患者均被纳入研究,并从电子病历中检索其临床数据。

结果

共纳入 145 例患者(存活组 121 例,非存活组 24 例)。非存活组下呼吸道感染的比例高于存活组(33.3%比 12.4%)(p < 0.05)。非存活组耐多药(MDR)肺炎克雷伯菌的比例高于存活组(41.7%比 16.5%)(p < 0.05)。多因素分析显示,序贯器官衰竭评估(SOFA)评分>6.5(OR,13.71;95%CI,1.05-179.84)、入住重症监护病房(ICU)(OR,2.27;95%CI,0.26-19.61)和胃肠道出血(OR,19.97;95%CI,1.11-361.02)是 KP-BSIs 患者死亡的独立危险因素。

结论

在所有 KP-BSIs 中,有相当比例的肺炎克雷伯菌来源于下呼吸道感染,且有相当比例的肺炎克雷伯菌为耐多药菌;然而,死亡率并未受此影响。SOFA 评分>6.5、入住 ICU 和胃肠道出血是 KP-BSI 患者死亡的独立危险因素。

相似文献

1
Clinical features and risk factors for mortality in patients with Klebsiella pneumoniae bloodstream infections.肺炎克雷伯菌血流感染患者的临床特征和死亡风险因素。
J Infect Dev Ctries. 2024 Jun 30;18(6):843-850. doi: 10.3855/jidc.18649.
2
Retrospective analysis of molecular characteristics, risk factors, and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.回顾性分析耐碳青霉烯类肺炎克雷伯菌血流感染的分子特征、危险因素和转归。
BMC Microbiol. 2024 Aug 22;24(1):309. doi: 10.1186/s12866-024-03465-4.
3
Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.希腊重症监护病房患者中产金属β-内酰胺酶/肺炎克雷伯菌碳青霉烯酶的肺炎克雷伯菌引起的血流感染:感染的危险因素和耐药类型对结局的影响。
Infect Control Hosp Epidemiol. 2010 Dec;31(12):1250-6. doi: 10.1086/657135. Epub 2010 Oct 25.
4
Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.2014-2018 年中国大型三级医院血流感染肺炎克雷伯菌的危险因素和死亡率:碳青霉烯类耐药的临床影响。
J Infect Public Health. 2020 May;13(5):784-790. doi: 10.1016/j.jiph.2019.11.014. Epub 2019 Dec 13.
5
Risk of death in Klebsiella pneumoniae bloodstream infections is associated with specific phylogenetic lineages.肺炎克雷伯菌血流感染的死亡风险与特定的系统发育谱系有关。
J Infect. 2024 May;88(5):106155. doi: 10.1016/j.jinf.2024.106155. Epub 2024 Apr 2.
6
Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.重症监护病房中产KPC肺炎克雷伯菌血流感染患者的感染危险因素及死亡预测因素。
Scand J Infect Dis. 2014 Sep;46(9):642-8. doi: 10.3109/00365548.2014.923106. Epub 2014 Jul 14.
7
A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.非移植患者耐碳青霉烯类肺炎克雷伯菌菌血症的危险因素和结局的回顾性分析。
J Infect Dis. 2020 Mar 16;221(Suppl 2):S174-S183. doi: 10.1093/infdis/jiz559.
8
A risk score based on pediatric sequential organ failure assessment predicts 90-day mortality in children with Klebsiella pneumoniae bloodstream infection.基于小儿序贯器官衰竭评估的风险评分预测儿童肺炎克雷伯菌血流感染 90 天死亡率。
BMC Infect Dis. 2020 Dec 2;20(1):916. doi: 10.1186/s12879-020-05644-w.
9
High mortality associated with inappropriate initial antibiotic therapy in hematological malignancies with Klebsiella pneumoniae bloodstream infections.高死亡率与血液感染肺炎克雷伯菌的血液恶性肿瘤初始抗生素治疗不当有关。
Sci Rep. 2024 Jun 6;14(1):13041. doi: 10.1038/s41598-024-63864-5.
10
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.产 ESBL 大肠埃希菌和产 ESBL 肺炎克雷伯菌血流感染的预测因素及死亡率比较。
Infect Control Hosp Epidemiol. 2018 Jun;39(6):660-667. doi: 10.1017/ice.2018.63. Epub 2018 Apr 5.

引用本文的文献

1
Biofilm Formation, Antibiotic Resistance, and Infection (BARI): The Triangle of Death.生物膜形成、抗生素耐药性与感染(BARI):死亡三角
J Clin Med. 2024 Sep 27;13(19):5779. doi: 10.3390/jcm13195779.